BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33992087)

  • 21. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer brain metastases: Molecular subtype, treatment and survival.
    Crozier JA; Cornell LF; Rawal B; Perez EA
    Breast Dis; 2016; 36(4):133-141. PubMed ID: 27802190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer--a phase II study.
    Shawky H; Tawfik H
    J Egypt Natl Canc Inst; 2014 Dec; 26(4):187-94. PubMed ID: 25294797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractionated stereotactic radiosurgery for patients with brain metastases.
    Minniti G; D'Angelillo RM; Scaringi C; Trodella LE; Clarke E; Matteucci P; Osti MF; Ramella S; Enrici RM; Trodella L
    J Neurooncol; 2014 Apr; 117(2):295-301. PubMed ID: 24488446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases.
    Ahmed KA; Freilich JM; Sloot S; Figura N; Gibney GT; Weber JS; Sarangkasiri S; Chinnaiyan P; Forsyth PA; Etame AB; Rao NG
    J Neurooncol; 2015 Mar; 122(1):121-6. PubMed ID: 25519302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
    Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
    BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series.
    Ippolito E; Silipigni S; Matteucci P; Greco C; Pantano F; D'Auria G; Quattrocchi CC; Floreno B; Fiore M; Gamucci T; Tonini G; Ramella S
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
    Kim JM; Miller JA; Kotecha R; Chao ST; Ahluwalia MS; Peereboom DM; Mohammadi AM; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Abraham J; Moore H; Budd GT; Suh JH
    Neuro Oncol; 2019 May; 21(5):659-668. PubMed ID: 30726965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
    Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
    Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated stereotactic radiosurgery for patients with progressive brain metastases.
    Minniti G; Scaringi C; Paolini S; Clarke E; Cicone F; Esposito V; Romano A; Osti M; Enrici RM
    J Neurooncol; 2016 Jan; 126(1):91-97. PubMed ID: 26369769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity.
    Diao K; Bian SX; Routman DM; Yu C; Ye JC; Wagle NA; Wong MK; Zada G; Chang EL
    J Neurooncol; 2018 Sep; 139(2):421-429. PubMed ID: 29696531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
    Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
    J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery.
    Vern-Gross TZ; Lawrence JA; Case LD; McMullen KP; Bourland JD; Metheny-Barlow LJ; Ellis TL; Tatter SB; Shaw EG; Urbanic JJ; Chan MD
    J Neurooncol; 2012 Dec; 110(3):381-8. PubMed ID: 23001361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
    Choi SW; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
    J Neurooncol; 2019 Dec; 145(3):571-579. PubMed ID: 31705245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
    Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
    Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.